Friday, October 3, 2025
NewsWave
No Result
View All Result
  • Home
  • World
  • USA
  • Business
  • Sports
  • Entertainment
  • Technology
Login
  • Home
  • World
  • USA
  • Business
  • Sports
  • Entertainment
  • Technology
Login
No Result
View All Result
Login
NewsWave
No Result
View All Result
Home Business

Netflix Adds 5 Million Users, Analysts Predict Price Hike

17 October 2024
in Business
0
Netflix Adds 5 Million Users, Analysts Predict Price Hike
Share on FacebookShare on Twitter



Netflix surpassed Wall Street expectations in its third-quarter earnings report by generating $9.825 billion in revenue and adding 5.1 million subscribers, exceeding analyst predictions. The company highlighted strong member engagement, with over 600 million users spending an average of two hours per day on the platform. Despite the positive results, analysts anticipate a potential price increase for U.S. users following recent hikes in Spain and Italy, with pricing currently ranging from $6.99 to $22.99 per month for different plan options.

Full Article

🪄 Creating a simple explanation...

Tags: addsAnalystshikeMillionNetflixPredictpriceUsers
Previous Post

Meat plant closure confirmed, hundreds of workers to be laid off

Next Post

Which one would you pick?

Related Posts

BNB Expected to Rise 45% in 2025 Compared to XRP
Business

BNB Expected to Rise 45% in 2025 Compared to XRP

by My News Wave
3 October 2025
0

BNB (CRYPTO: BNB) has risen by 45% this year, while XRP (CRYPTO: XRP) has gained 27%, but their growth is driven by different factors that will impact future performance. Analyzing these distinctions will help determine which cryptocurrency represents a better investment opportunity. Want More Context? 🔎

Read more
Pfizer Signs Drug Pricing Agreement with President Trump  
Is Pfizer Stock a Good Investment?
Business

Pfizer Signs Drug Pricing Agreement with President Trump Is Pfizer Stock a Good Investment?

by My News Wave
3 October 2025
0

Recent concerns for pharmaceutical companies have centered on President Trump's plans to reduce drug prices and impose tariffs on imports, causing investor hesitation. However, Pfizer became the first drugmaker to secure a pricing agreement with Trump, gaining a three-year exemption from import tariffs, which led to a 14% surge in its stock over two trading sessions. Want More Context? 🔎

Read more
CoreWeave’s Valuation Increases After Meta Partnership
Business

CoreWeave’s Valuation Increases After Meta Partnership

by My News Wave
2 October 2025
0

CoreWeave (NASDAQ: CRWV), an AI cloud infrastructure company that transitioned from crypto mining, reported a remarkable 206% revenue increase to $1.21 billion in Q2, driven by the surging demand for AI computing power from clients like Microsoft, Nvidia, and OpenAI. The stock soared 12% after announcing a significant new deal with Meta Platforms (NASDAQ: META), further boosting its growth prospects. Want More Context? 🔎

Read more
D-Wave Quantum Stock Rises 14% Today
Business

D-Wave Quantum Stock Rises 14% Today

by My News Wave
2 October 2025
0

Shares of D-Wave Quantum (NYSE: QBTS) surged 14% on Thursday, contrasting with a flat S&P 500 and a 0.4% gain in the Nasdaq Composite. This increase followed Rigetti Computing's announcement of selling two Novera quantum systems for a combined $5.7 million, signaling a positive outlook for the quantum market and boosting investor confidence in D-Wave. Want More Context? 🔎

Read more
Nike Reports Return to Revenue Growth  
Is Now the Right Time to Invest in Nike Stock?
Business

Nike Reports Return to Revenue Growth Is Now the Right Time to Invest in Nike Stock?

by My News Wave
2 October 2025
0

Nike (NYSE: NKE) is showing signs of recovery, reporting a slight revenue growth in Q1 of fiscal 2026 after challenging periods, with shares rising as investor confidence in new leadership grows. Despite progress in key categories, concerns about competitive pressures and margins persist, and the stock may not be considered cheap given its recent performance. Want More Context? 🔎

Read more
AstraZeneca Stock Rises 10% Following Tariff Announcement  
Is AstraZeneca a Good Investment?
Business

AstraZeneca Stock Rises 10% Following Tariff Announcement Is AstraZeneca a Good Investment?

by My News Wave
2 October 2025
0

Shares of AstraZeneca (NASDAQ: AZN) surged over 10% this week following positive clinical results for Enhertu in HER2-positive breast cancer and a significant deal between Pfizer (NYSE: PFE) and the Trump administration, where Pfizer will reduce drug prices and invest $70 billion domestically, gaining a three-year exemption from tariffs on pharmaceutical imports. This agreement was highlighted during a press conference with Pfizer CEO Albert Bourla and President Trump. Want More Context? 🔎

Read more
NewsWave

News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.

CATEGORIES

  • Africa
  • Asia Pacific
  • Australia
  • Business
  • Canada
  • Entertainment
  • Europe
  • India
  • Middle East
  • New Zealand
  • Sports
  • Technology
  • UK
  • USA
  • World

LATEST NEWS STORIES

  • Apple Removes ICE Tracking App from App Store
  • Sask. man criticizes mother’s extended hospital stay in hallway
  • Israel uses tear gas at school shelter in Western Gaza Dozens affected by gas exposure
  • About Us
  • Disclaimer
  • Privacy Policy
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • USA
  • Business
  • Sports
  • Entertainment
  • Technology

Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In